Genitourinary Malignancies: Current Perspectives in Bladder, Kidney, and Testis Cancer

The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 18, 2005

Share article


Conference Dates: Friday, November 4, 2005
Conference Location: The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia, PA

Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania

Conference Objectives: At the completion of this conference, participants should be able to:

  1. Identify risk factors in bladder cancer and how those factors influence treatment options;
  2. Discuss treatment options for patients with advanced bladder disease;
  3. Describe the role of surgical intervention for patients with kidney cancer;
  4. Identify new approaches and data in the treatment of kidney cancer;
  5. Evaluate the role of genetics in patients with testis cancer;
  6. Describe new approaches in the treatment of testis cancer

Who Should Attend: Urologic surgeons, medical oncologists, radiation oncologists, pathologists, hematology oncology fellows, urologic oncology nurses, and other health care professionals involved in the treatment of patients with genitourinary cancer.

Conference Agenda:

  • 8:30-8:40 Welcome and Introduction. S. Bruce Malkowicz, MD
  • 8:40-9:10 Tumor Markers in the Diagnosis and Surveillance of Bladder Cancer. S. Bruce Malkowicz, MD
  • 9:10-9:50 Pathologic Dilemmas in Bladder Cancer. Priti Lal, MD
  • 9:50-10:20 Contemporary Issues in the Treatment of Superficial Bladder Cancer. Michael O'Donnell, MD, FACS
  • 10:30-11:10 Contemporary Management of Muscle Invasive Bladder Cancer. S. Bruce Malkowicz, MD
  • 11:10-11:50 The Role of Systemic Chemotherapy in Invasive Bladder Cancer. David J. Vaughn, MD
  • 1:15-1:45 The Spectrum of Kidney Cancer. John E. Tomaszewski, MD
  • 1:45-2:25 Surgical Management of Renal Cell Carcinoma. Steven C. Campbell, MD, PhD
  • 2:25-3:05 Minimally Invasive Approaches to Small Renal Masses. Timothy W.I. Clark, MD
  • 3:05-3:25 Advances in the Treatment of Metastatic Renal Cell Carcinoma. Keith T. Flaherty, MD
  • 3:45-4:15 The Genetic Aspects of Testis Cancer. Katherine L. Nathanson, MD
  • 4:15-4:55 Contemporary Clinical Care of Testis Cancer. David J. Vaughn, MD

Registration Information: To register or receive a conference brochure, please contact Mary Graham at grahamm@mail.med.upenn.edu or by phone at 215-662-7328.

Conference Fees: $190.00 for Physicians; $95.00 for Nurses and other health care professionals, No fee for faculty, staff, fellows at students of University of Pennsylvania

Online Registration: All fields are required.

First Name:
Last Name:
Email Address:
Academic Degree:
Medical Specialty:
Affiliation:
(Hospital, Office, Company)
Address:

( Affiliation Home)
City:
State   ZIP Code:
Daytime Telephone #:
Fax #:
Registration: $190 - Physicians
   Credit Card
   Check

$95 - Nurses & other health care professionals
   Credit Card
   Check

Free - faculty, staff, fellows & students of the University of Pennsylvania

   

Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:

Mary Graham
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854

Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Continuing Education: Yes

Miscellany: The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.